J. Kerst

发表

Randomized phase II/III trial assessing gemcitabine/carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer who are unfit for cisplatin-based chemotherapy: EORTC study 30986.

R. Sylvester, J. Bellmunt, J. Lorent, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).

M. Piccart, U. Dafni, E. D. de Vries, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Correcetions to "A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)".

M. Piccart, U. Dafni, E. D. de Vries, 2017 .

Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency

S. Rodenhuis, J. Beijnen, A. Huitema, 2008, Cancer Chemotherapy and Pharmacology.

18F-FDG PET/CT for monitoring induction chemotherapy in patients with primary inoperable penile carcinoma: first clinical results

A. Bergman, S. Horenblas, R. V. Valdés Olmos, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.

Arno Floore, Daphne de Jong, Anke Witteveen, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Dutch guidelines for the diagnosis and treatment of chronic lymphocytic leukaemia.

A. Kater, M. Nijziel, R. Raymakers, 2016, The Netherlands journal of medicine.

Response to induction chemotherapy and surgery in non-organ confined bladder cancer: a single institution experience.

H. G. van der Poel, W. Meinhardt, A. Bergman, 2013, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

M. Piccart, U. Dafni, E. D. de Vries, 2016, ESMO Open.

FDG-positron emission tomography/computerized tomography for monitoring the response of pelvic lymph node metastasis to neoadjuvant chemotherapy for bladder cancer.

B. V. van Rhijn, S. Horenblas, W. Vogel, 2013, The Journal of urology.

Symptomatic brain metastases from small-cell carcinoma of the urinary bladder: The Netherlands Cancer Institute experience and literature review.

S. Horenblas, G. Sonke, A. Bex, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Tr

S. Sleijfer, J. Blay, S. Litière, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder

W. Meinhardt, R. Meijer, S. Horenblas, 2013, International journal of urology : official journal of the Japanese Urological Association.

A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.

J. Blay, F. Collin, S. Litière, 2015, European journal of cancer.

Imatinib‐induced agranulocytosis in patients with gastrointestinal stromal tumors

S. Sleijfer, H. Gelderblom, A. Verschoor, 2015, Journal of clinical pharmacology.

Risk of Solid Cancer After Treatment of Testicular Germ Cell Cancer in the Platinum Era.

J. Witjes, G. Groenewegen, F. V. van Leeuwen, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical outcome of robot-assisted residual mass resection in metastatic nonseminomatous germ cell tumor

H. G. van der Poel, J. Bosch, R. Meijer, 2020, World journal of urology.

Molecular characterization of gastric adenocarcinoma diagnosed in patients previously treated for Hodgkin lymphoma or testicular cancer

L. Rigter, G. Meijer, F. V. van Leeuwen, 2022, PloS one.

Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study.

S. Sleijfer, P. Rutkowski, P. Hohenberger, 2014, European journal of cancer.

Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).

A. Hekman, W. Gerritsen, J. Kerst, 1998, Experimental hematology.

Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.

J. Schornagel, W. Meinhardt, H. van Tinteren, 2005, The Journal of urology.

A phase I study on the combination of neoadjuvant radiotherapy plus pazopanib in patients with locally advanced soft tissue sarcoma of the extremities

S. Sleijfer, H. V. van Boven, F. van Coevorden, 2015, Acta oncologica.

Interleukin-6 is a survival factor for committed myeloid progenitor cells.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Experimental hematology.

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072.

S. Sleijfer, S. Litière, J. Verweij, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin

A. Bergman, M. S. Heijden, R. Meijer, 2016, World Journal of Urology.

The Role of Chemotherapy and Radiotherapy in the Treatment of Penile Cancer

L. Moonen, A. Bergman, S. Horenblas, 2011 .

Sentinel node biopsy in clinical stage I testicular cancer enables early detection of occult metastatic disease

H. G. van der Poel, J. Bosch, R. Meijer, 2019, BJU international.

An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.

S. Rodenhuis, H. van Tinteren, J. Kerst, 2013, Urologic oncology.

Neoadjuvant Systemic Treatment of Primary Angiosarcoma

J. Beijnen, W. T. van der Graaf, W. V. van Houdt, 2020, Cancers.

Recruiting Adolescent and Young Adult Cancer Survivors for Patient-Reported Outcome Research: Experiences and Sample Characteristics of the SURVAYA Study

R. Bijlsma, O. Husson, W. T. van der Graaf, 2022, Current oncology.

Occult lymph node metastases in patients with carcinoma invading bladder muscle: incidence after neoadjuvant chemotherapy and cystectomy vs after cystectomy alone

W. Meinhardt, A. Bergman, M. S. Heijden, 2014, BJU international.

Induction chemotherapy followed by surgery in node positive bladder cancer.

H. G. van der Poel, W. Meinhardt, E. van Werkhoven, 2014, Urology.

Carboplatin based induction chemotherapy for nonorgan confined bladder cancer--a reasonable alternative for cisplatin unfit patients?

A. Bergman, H. van Tinteren, R. Meijer, 2012, The Journal of urology.

Granulocyte colony-stimulating factor administration to healthy volunteers: analysis of the immediate activating effects on circulating neutrophils.

C. Hack, J. Nuijens, R. V. van Oers, 1994, Blood.

Recombinant granulocyte colony-stimulating factor administration to healthy volunteers: induction of immunophenotypically and functionally altered neutrophils via an effect on myeloid progenitor cells.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Blood.

Granulocyte colony-stimulating factor induces hFc gamma RI (CD64 antigen)-positive neutrophils via an effect on myeloid precursor cells.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Blood.

Concurrent Radiotherapy and Panitumumab after Lymph Node Dissection and Induction Chemotherapy for Invasive Bladder Cancer

A. Broeks, P. Nederlof, A. Bergman, 2019, The Journal of urology.

Neoadjuvant chemotherapy in advanced penile carcinoma.

S. Horenblas, J. Kerst, Joost A. P. Leijte, 2007, European urology.

Penile Cancer Neoadjuvant Chemotherapy in Advanced Penile Carcinoma

S. Horenblas, J. Kerst, Joost A. P. Leijte, 2007 .

Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy; results from the HOVON 109 study.

A. Langerak, A. Kater, M. V. van Oers, 2020, Experimental hematology.

Randomized phase II/III trial comparing gemcitabine/carboplatin (GC) and methotrexate/carboplatin/vinblastine (M-CAVI) in patients (pts) with advanced urothelial cancer (UC) unfit for cisplatin-based chemotherapy (CHT): Phase III results of EORTC study 30986.

J. Maroto, R. Sylvester, J. Bellmunt, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia

A. Kater, M. V. van Oers, R. Raymakers, 2018, Haematologica.

A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer

H. G. van der Poel, B. V. van Rhijn, S. Langbein, 2020, Urology Annals.

Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients.

A. Hart, J. Haanen, O. Nieweg, 2005, European journal of cancer.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

J. Blay, C. Fisher, S. Litière, 2014, The Lancet. Oncology.

Risk of diabetes after para-aortic radiation for testicular cancer

J. Witjes, G. Groenewegen, F. V. van Leeuwen, 2018, British Journal of Cancer.

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial.

L. Collette, S. Fosså, P. Albers, 2015, The Lancet. Oncology.

Inguinal recurrence following therapeutic lymphadenectomy for node positive penile carcinoma: outcome and implications for management.

H. V. van Boven, L. Moonen, E. van Werkhoven, 2011, The Journal of urology.

Randomized phase II/III trial assessing gemcitabine/ carboplatin and methotrexate/carboplatin/vinblastine in patients with advanced urothelial cancer "unfit" for cisplatin-based chemotherapy: phase II--results of EORTC study 30986.

R. Sylvester, J. Bellmunt, M. D. De Santis, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[Migrating swellings from Asia: gnathostomiasis].

P. D. de Vries, J. Kerst, L. Kortbeek, 2001, Nederlandsch tijdschrift voor geneeskunde.

M. Piccart, U. Dafni, E. D. de Vries, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Alpha 4 beta 1 and alpha 5 beta 1 are differentially expressed during myelopoiesis and mediate the adherence of human CD34+ cells to fibronectin in an activation-dependent way.

R. V. van Oers, C. E. van der Schoot, I. Slaper-Cortenbach, 1993, Blood.

Local production of interleukin-6 during acute rejection in human renal allografts.

J. Weening, J. Kerst, M. Raasveld, 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Survival and Cost-Effectiveness of Trabectedin Compared to Ifosfamide Monotherapy in Advanced Soft Tissue Sarcoma Patients

S. Sleijfer, H. Gelderblom, A. Reyners, 2019, Sarcoma.

Neoadjuvant Imatinib in Locally Advanced Gastrointestinal Stromal Tumors (GIST): The EORTC STBSG Experience

S. Sleijfer, S. Bonvalot, A. Cesne, 2013, Annals of Surgical Oncology.

Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.

M. Hauptmann, E. Noordijk, M. D. De Bruin, 2009, International journal of radiation oncology, biology, physics.

Prolonged low dose IL-2 and thalidomide in progressive metastatic renal cell carcinoma with concurrent radiotherapy to bone and/or soft tissue metastasis: a phase II study

J. Haanen, W. Boogerd, L. Dewit, 2005, Cancer Immunology, Immunotherapy.

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

L. Collette, C. Théodore, I. Bodrogi, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

S. Sleijfer, S. Litière, J. Verweij, 2014 .

Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of Life

J. Witjes, G. Groenewegen, F. V. van Leeuwen, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extended Continuous Oral Temozolomide in Patients with Progressive Metastatic Renal Cell Carcinoma Not Responding to Interferon Alpha 2b

H. van Tinteren, S. Horenblas, A. Bex, 2005, Journal of chemotherapy.

A randomized phase II/III study of cabazitaxel versus vinflunine in metastatic or locally advanced transitional cell carcinoma of the urothelium (SECAVIN)

J. Bellmunt, M. Los, R. de Wit, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Final results of EORTC intergroup randomized phase III trial comparing immediate versus deferred chemotherapy after radical cystectomy in patients with pT3T4 and/or N+ M0 transitional cell carcinoma (TCC) of the bladder.

S. Fosså, P. Albers, R. Sylvester, 2014 .

Brain Hyperconnectivity >10 Years After Cisplatin-Based Chemotherapy for Testicular Cancer

Myrle M. Stouten-Kemperman, Michiel B. de Ruiter, Willem Boogerd, 2018, Brain Connect..

E-selectin and very late activation antigen-4 mediate adhesion of hematopoietic progenitor cells to bone marrow endothelium

W. Gerritsen, C. E. van der Schoot, P. Rood, 2000, Annals of Hematology.

Platelet volume analysis in thrombocytopenia in relation to bleeding tendency.

J. Kerst, A. von dem Borne, E. R. van der Vorm, 2009, Scandinavian journal of haematology.

Risk of diabetes after para-aortic radiation for testicular cancer

J. Witjes, G. Groenewegen, F. V. van Leeuwen, 2018, British Journal of Cancer.

Learning from long‐term adolescent and young adult (AYA) cancer survivors regarding their age‐specific care needs to improve current AYA care programs

R. Bijlsma, O. Husson, C. Vlooswijk, 2023, Cancer medicine.

[Young adults with Ewing's sarcoma].

J. Peterse, S. Linn, F. van Coevorden, 2004, Nederlands tijdschrift voor geneeskunde.

U. Dafni, J. Kerst, A. Sobrero, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

J. Blay, C. Fisher, S. Litière, 2014, The Lancet. Oncology.

A phase II multicentre study of irinotecan (CPT 11) in combination with cisplatin (CDDP) in metastatic or locally advanced penile carcinoma (EORTC PROTOCOL 30992).

L. Collette, C. Théodore, I. Bodrogi, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Complete resection of recurrent and initially unresectable dermatofibrosarcoma protuberans downsized by Imatinib

J. A. van der Hage, H. V. van Boven, F. van Coevorden, 2013, World Journal of Surgical Oncology.

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

U. Dafni, J. Kerst, A. Sobrero, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.